Journal article
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
Abstract
BACKGROUND: The aim of this study was to examine the relative efficacy and safety of boceprevir and telaprevir, when used in combination with pegylated interferon alpha and ribavirin, using an indirect comparison meta-analysis.
METHODS: Published phase II and phase III randomized placebo-controlled trials examining the efficacy of boceprevir and telaprevir in chronic hepatitis C virus genotype 1 infected adult populations were included. The …
Authors
Cooper CL; Druyts E; Thorlund K; Nachega JB; Khoury ACE; O’Regan C; Mills EJ
Journal
Therapeutics and Clinical Risk Management, Vol. 8, No. 0, pp. 105–130
Publisher
Taylor & Francis
Publication Date
2012
DOI
10.2147/tcrm.s29830
ISSN
1176-6336